Miniatura

Fitxers

609851.pdf (535.18 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2010-12-21

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/46391

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1136/thx.2010.154484

Resum

Background Chronic obstructive pulmonary disease (COPD) is increasingly considered a heterogeneous condition. It was hypothesised that COPD, as currently defined, includes different clinically relevant subtypes. Methods To identify and validate COPD subtypes, 342 subjects hospitalised for the first time because of a COPD exacerbation were recruited. Three months after discharge, when clinically stable, symptoms and quality of life, lung function, exercise capacity, nutritional status, biomarkers of systemic and bronchial inflammation, sputum microbiology, CT of the thorax and echocardiography were assessed. COPD groups were identified by partitioning cluster analysis and validated prospectively against cause-specific hospitalisations and all-cause mortality during a 4 year follow-up. Results Three COPD groups were identified: group 1 (n ¼ 126, 67 years) was characterised by severe airflow limitation (postbronchodilator forced expiratory volume in 1 s (FEV 1 ) 38% predicted) and worse performance in most of the respiratory domains of the disease; group 2 (n ¼ 125, 69 years) showed milder airflow limitation (FEV 1 63% predicted); and group 3 (n ¼ 91, 67 years) combined a similarly milder airflow limitation (FEV 1 58% predicted) with a high proportion of obesity, cardiovascular disorders, iabetes and systemic inflammation. During follow-up, group 1 had more frequent hospitalisations due to COPD (HR 3.28, p < 0.001) and higher all-cause mortality (HR 2.36, p ¼ 0.018) than the other two groups, whereas group 3 had more admissions due to cardiovascular disease (HR 2.87, p ¼ 0.014). Conclusions In patients with COPD recruited at their first hospitalisation, three different COPD subtypes were identified and prospectively validated:"severe respiratory COPD","moderate respiratory COPD", and"systemic COPD'

Matèries

Malalties de l'aparell respiratori, Malalties pulmonars obstructives cròniques, Assaigs clínics

Matèries (anglès)

Respiratory organs diseases, Chronic obstructive pulmonary diseases, Clinical trials

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

GARCÍA AYMERICH, Judith, GOMEZ, Federico  p., BENET MORA, Marta, FARRERO, Eva, BASAGAÑA, Xavier, GAYETE, Àngel, PARE I BARDERA, J. carles, FREIXA, Xavier, FERRER, Jaume, FERRER MONREAL, Antonio, ROCA ELIAS, Josep, GALDIZ, Juan b., SAULEDA, Jaume, MONSÓ, Eduard, GEA GUIRAL, Joaquim, BARBERÀ I MIR, Joan albert, AGUSTÍ GARCÍA-NAVARRO, Àlvar, ANTÓ I BOQUÉ, Josep maria. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. _Thorax_. 2010. Vol. 66, núm. 430-437. [consulta: 14 de gener de 2026]. ISSN: 0040-6376. [Disponible a: https://hdl.handle.net/2445/46391]

Exportar metadades

JSON - METS

Compartir registre